Lahore September 20 2024: CITI PHARMA LTD, Become Pakistan’s 1st Exporter to USA for Nutraceutical products, according to company filing to the exchange.
Share price of the company surge PKR 1.13 or 3.28 percent in today’s trading at Pakistan Stock Exchange.
CITI PHARMA Pakistan’s largest API manufacturer is proud to announce this news as Pakistan’s 1st Nutraceutical products receive FDA approval and formal ground launch in September 2024. Conceitedly announce approvals in following categories:
Fertility
Weight management
Stress and Mood booster
Hair & Skin Care
Joint and Muscle pains
This approval underscores Citi Pharma’s adherence to rigorous international quality standards, allowing the company to enter the highly competitive U.S. market by exporting the finished nutraceutical products.
CITI PHARMA offers an extensive section of API, Formulations, Nutraceutical product line for both Local and Global customers. Their product lines Tablets, Capsules, Powder Sachets, Syrups, Ointments and Gels, Injections, Infusion and Sus.
What sets Citi Pharma Ltd apart is their unwavering commitment to quality and purity. All products are crafted to the best of the product line, ensuring the highest standard of care for life.
Leading this groundbreaking initiative are CEO Mr. Rizwan. His vision and dedication to offering best quality products have made Citi Pharma Ltd a game-changer in the industry.
The financial implications are significant, with the company expecting to generate approximately $3 million annually from this new revenue stream, alongside impressive profit margins of 25% to 30%. This FDA approval not only boosts Citi Pharma’s credibility but also positions the company as a growing global player, potentially attracting further investment and international partnerships.
We have successfully received the payment of USD 109,500 for our first shipment.
